SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ethereum is a global, open-source platform for decentralized applications. In other words, the vision is to create a world computer that anyone can build applications in a decentralized manner; while all states and data are distributed and publicly accessible. Ethereum supports smart contracts in which developers can write code in order to program digital value. Examples of decentralized apps (dapps) that are built on Ethereum includes tokens, non-fungible tokens, decentralized finance apps, lending protocol, decentralized exchanges, and much more.  On Ethereum, all transactions and smart contract executions require a small fee to be paid. This fee is called Gas. In technical terms, Gas refers to the unit of measure on the amount of computational effort required to execute an operation or a smart contract. The more complex the execution operation is, the more gas is required to fulfill that operation. Gas fees are paid entirely in Ether (ETH), which is the native coin of the blockchain. The price of gas can fluctuate from time to time depending on the network demand.

Ethereum

Ethereum is trending as the crypto market experiences volatility, with community members debating potential bottom levels and the impact of external factors like a possible government shutdown. Discussions also include the influence of market manipulators and the potential for a significant rally in October. Bullish sentiment persists among some, who view the current prices as a buying opportunity before a predicted surge.

Fusion Fuel Green Plc engages in the research and development of solar technologies. It develops a process and technology to produce emission-free green hydrogen using concentrated photovoltaic technology. The company was founded in 2018 and is headquartered in Dublin, Ireland.

Fusion Fuel Green Ltd - Ordinary Shares - Class A

Fusion Fuel Green PLC

HTOO is trending due to news of a non-binding term sheet for hydrogen infrastructure investments, sparking discussions about the company's potential growth in the green energy sector. Community members are actively debating the significance of the deal, with some expressing skepticism based on past performance, while others are focusing on the stock's low float and potential for a squeeze. The conversation also includes the company's NASDAQ compliance status.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure ($QURE) is trending due to promising trial data for its Huntington's disease gene therapy, showing significant slowing of disease progression. Despite positive efficacy signals, the community is discussing concerns about a recent public offering and potential dilution. The stock's movement is also influenced by broader biotech sector momentum, with some comparing it to other high-flying gene therapy stocks.

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Immuneering Corp - Ordinary Shares Class A

IMRX is trending due to positive clinical trial results for its pancreatic cancer treatment, showing significant overall survival rates. However, the stock experiences volatility as the company announced a public offering and concurrent private placement, raising concerns about potential dilution among investors. The community is actively debating the implications of the offering and its impact on the stock's future performance, especially with Sanofi's investment.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is trending as the community discusses its valuation relative to competitors, highlighting strong revenue growth and profitability while questioning market manipulation and short interest. Some are speculating on a potential buyout and anticipating positive news regarding pediatric approval and pipeline developments. Community members express frustration with the stock's price action despite positive earnings reports.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz is trending due to positive earnings reports and discussions around its strategic partnership with Amazon to sell used vehicles, sparking optimism about increased visibility and profitability. Community members are actively debating the potential for a short squeeze given the stock's high short interest and comparing it to Carvana's market position, with some speculating about future partnerships.

The address GaPbGp23pPuY9QBLPUjUEBn2MKEroTe9Q3M3f2Xpump corresponds to a token on the Solana blockchain, specifically an SPL (Solana Program Library) token. This address is likely the mint address for a specific token, which is used to identify the token on the Solana network. Based on the context and available information, this token appears to be associated with the pump.fun platform, as the address ends with "pump," which is a common identifier for tokens created via this platform. GaPbGp23pPuY9QBLPUjUEBn2MKEroTe9Q3M3f2Xpump is the mint address of an SPL token on the Solana blockchain. The mint address is a unique identifier for a token, storing metadata like total supply and mint authority. The "pump" in the address strongly suggests it was created on solanapump (commonly known as pump.fun), a popular Solana-based platform for launching meme coins and other tokens. Pump.fun allows users to create and trade tokens easily, often with a focus on community-driven or speculative projects like memecoins.

Shitcoin

$SHITCOIN.X is trending as a new Solana-based meme coin gaining traction, with community members actively discussing its potential for explosive growth and comparing it to other coins like $FARTCOIN.X and $DOGE.X. Despite its name, some traders believe it could be the next big opportunity, while others express skepticism about its long-term value in the crypto space.

Endeavour Silver Corp. is a mineral company, which engages in the evaluation, acquisition, development and exploitation of precious metal properties in Mexico and Chile. The firm's projects include the Terronera property in Jalisco, the El Compas property, the Guanacevi Mine in Durango, Bolanitos Mines in Guanajuato, and the Parral project in Chihuahua, Mexico. The company was founded by Bradford James Cooke on March 11, 1981 and is headquartered in Vancouver, Canada.

Endeavour Silver Corp.

Endeavour Silver ($EXK) is trending as silver prices surge to multi-year highs, fueling optimism for silver miners. The community is discussing the potential for a massive breakout, with some eyeing a target of $20, driven by the anticipation of the Terronera mine reaching full production. Investors are also weighing in on the impact of silver's strategic metal designation and potential short squeezes.

Priceless is a memecoin launched on 5/7/25. This memecoin indicates something being precious, something that it's value cannot be determined. Priceless is a groundbreaking crypto project launched on Studio, empowering communities to build together effortlessly. With a focus on seamless collaboration, Priceless fosters innovation and connection, enabling users to create, share, and grow without barriers. Join the revolution and shape the future!

Priceless

Priceless.X is trending as the community discusses potential opportunities in other cryptocurrencies, with some users suggesting a look at GASH.X. The conversations appear to be driven by the desire to find the next cryptocurrency with significant growth potential. Community members are actively sharing and evaluating different options.

Eason Technology Ltd. engages in the provision of loan facilities to micro, small and medium size enterprises, and sole proprietors. It also offers microfinance lending services. The company was founded by Qi Ming Xu and Kang Kai Zeng on June 24, 2010 and is headquartered in Wuhan, China.

Eason Technology Ltd. - ADR

Eason Technology Ltd ADR

Eason Technology is trending as traders discuss its low float and potential for a significant price surge, drawing comparisons to previous runners like $QMMM. The community is anticipating news, possibly related to a past Bitcoin treasury announcement or the company's blockchain acquisition, as a catalyst for a breakout. Some are citing technical indicators suggesting a potential upward move.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Halozyme Therapeutics and Synopsys have been highlighted as Zacks Bull and Bear of the Day

Halozyme shines with strong growth and partnerships, while Synopsys struggles after earnings miss and lowered outlook.

Bear of the Day: Synopsys (SNPS)

Leading provider of electronic design automation for semis reports big EPS miss and spooks investors

Intel Corp. (INTC) stock was on fire last week, extending the momentum it has been witnessing this year, as the struggling chipmaker agreed to receive a $5 billion investment from artificial intelligence (AI) stalwart Nvidia (NVDA).The stock logged a weekly gain of nearly 23%, marking the best week since the week ended Jan. 31, 1975, according to Dow Jones&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.marketwatch.com/livecoverage/stock-market-today-dow-set-for-300-point-rise-as-s-p-500-eyes-record-ahead-of-retail-sales/card/intel-s-stock-hasn-t-had-a-week-this-strong-in-50-years-ZYBun6S0POdGwUzg8eAE">data.</a>&nbsp; For the year, the stock is now up 47.53%, outperforming&nbsp;<a href="https://stocktwits.com/symbol/NVDA">Nvidia stock’s</a> 32% gain and the&nbsp;<a href="https://stocktwits.com/symbol/SOXX">iShares Semiconductor ETF’s</a> (SOXX) 24% rise.&nbsp;Intel ended with the best weekly gains among S&amp;P 500 stocks last week. By virtue of Intel’s year-to-date (YTD) gains, the stock is now&nbsp;positioned in the overbought zone, potentially leaving traders concerned about whether they are late to the party.The 14-day relative strength indicator (RSI) for the <a href="https://stocktwits.com/symbol/INTC">Intel stock</a> is currently at 71.83. A reading above 70 suggests that the stock is in the overbought zone. An overbought stock is one whose price has risen rapidly and is at levels beyond what its underlying fundamentals or intrinsic value suggest.&nbsp;That said, the overbought fears may appear overblown if one considers the underperformance over the past five years (down about 8%).&nbsp;<figure class="image"><img style="aspect-ratio:2400/1240;" src="https://news.stocktwits-cdn.com/Intel_5_year_chart_png_8b6626b98b.webp" alt="Intel-5-year chart.png" width="2400" height="1240"><figcaption>INTC 5-year stock chart | Source: Koyfin</figcaption></figure>After struggling for years with product missteps and a business model that wasn’t nimble enough to embrace new technologies, Intel, under its new CEO Lip-Bu Tan, began right-sizing operations. The stock started to turn the corner as it factored in the possibility of a reversal in fortunes. The decision by President Donald Trump’s administration to take a stake in the company provided a&nbsp;boost to the company and its stock. The Nvidia news served to accelerate the rally’s momentum.That said, Intel’s forward price-earnings (P/E) multiple is a hefty 139 times, notably higher than Nvidia’s 31 times, according to Koyfin.The short interest in Intel’s stock is 1.5%, according to Koyfin.The runup has not deterred retail traders on Stocktwits. They continued to have ‘extremely bullish’ (80/100) sentiment toward the Nvidia stock, and the message volume was at ‘extremely high’ levels.Among the other top S&amp;P 500 gainers for the week are:<ul><li>Snyopsys (SNPS), a provider of electronic design automation software products used to design and test integrated circuits: +16.46%</li><li>Cybersecurity company CrowdStrike (CRWD): +15.24%</li><li>Chip testing equipment maker Applied Materials (AMAT):&nbsp; +13.29%</li><li>Data storage solutions company Seagate (STX): +12.88%</li></ul>&nbsp;The year-to-date performances stack up as follows:YTD Performance: INTC Vs. SNPS Vs. CRWD Vs. AMAT Vs. STX<figure class="image"><img style="aspect-ratio:2400/1240;" src="https://news.stocktwits-cdn.com/Intelvs_others_YTD_png_9ff6cf061c.webp" alt="Intelvs othersYTD.png" width="2400" height="1240"></figure>Source: KoyfinAll stocks, except Synopsys, are in overbought territory.&nbsp;RSI: INTC Vs. SNPS Vs. CRWD Vs. AMAT Vs. STX&nbsp;<figure class="image"><img style="aspect-ratio:2400/1240;" src="https://news.stocktwits-cdn.com/INTC_RSI_png_ff3328916e.webp" alt="INTC RSI.png" width="2400" height="1240"></figure>Source: KoyfinSynopsys came under significant selling pressure earlier this month after the company posted&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-snopsys-stock-plummeted-19-in-after-hours-trading-today/chwjxuIRdM2">weaker-than-expected quarterly results</a> and issued downbeat guidance.Baird semiconductor analyst Tristan Gerra&nbsp;views the Nvidia investment as an incremental positive for Intel, potentially enhancing market share gains and driving foundry revenue growth.The Koyin-compiled consensus analysts’ price target for Intel is $24.87, implying roughly 16% downside from Friday’s close.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nasdaq-s-and-p-500-futures-pause-after-market-s-record-run/chDQ0Q7R3ck">Nasdaq, S&amp;P 500 Futures Pause After Market’s Record Run — Strategist Says Sell-Off ‘Very, Very Likely’</a>

A view of Intel office building on August 22, 2025, in Beijing, China.

Intel, Synopsys, CrowdStrike, Applied Materials, Seagate Lead S&P 500 Weekly Gains — But One Isn’t Overbought

Intel’s forward price-earnings (P/E) multiple is a hefty 139 times, notably higher than Nvidia’s 31 times, according to Koyfin.

Equity

Company News for Sep 11, 2025

Companies in The News Are: SNPS, AAPL, KMI, GME

Synopsys Inc. (SNPS) stock tumbled 34% on Wednesday after the firm posted downbeat earnings and multiple Wall Street firms revised their price targets on the chip design software company, citing the disappointing third-quarter (Q3) performance and persistent concerns about its intellectual property (IP) segment.The company’s Q3 revenue of&nbsp;$1.74 billion and adjusted earnings per share (EPS) of $3.39 both came in below the analysts’ consensus estimate of $1.77 billion and $3.75, according to Fiscal AI data.&nbsp;Retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.<figure class="image"><img style="aspect-ratio:935/112;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_10_101501_png_175899a5a4.webp" alt="SNPS’s Sentiment Meter and Message Volume as of 10:00 a.m. ET on Sep. 10, 2025 | Source: Stocktwits" width="935" height="112"><figcaption>SNPS’s Sentiment Meter and Message Volume as of 10:00 a.m. ET on Sep. 10, 2025 | Source: Stocktwits</figcaption></figure>The stock experienced a 2,883% increase in user message count in 24 hours. A bullish Stocktwits user called the stock’s fall ‘overreaction’.<stembedurl>https://stocktwits.com/dpnaidu27/message/628120187</stembedurl>Another user said they have initiated a position.<stembedurl>https://stocktwits.com/MZel/message/628130528</stembedurl>Rosenblatt analyst Blair Abernethy downgraded Synopsys from ‘Buy’ to ‘Neutral’ and cut the firm’s price target from $650 to $605. Abernethy noted that the company's IP pivot will take several quarters to stabilize, which evokes heightened risk.&nbsp;The analyst also cited management's explanation, which involved China export constraints, foundry-related slowdowns, and underperforming IP product strategies, as contributing factors to the miss.Needham analyst Charles Shi also lowered the price target to $550 from $660, but maintained a ‘Buy’ rating. Shi labeled the quarter as "mixed," with the IP business showing unexpected weakness.&nbsp;Stifel analyst Ruben Roy echoed those concerns, trimming the target to $550 from $650 while keeping a ‘Buy’ stance. Roy said the IP drag was mostly due to cautious behavior from Chinese clients after U.S. export regulations took effect, combined with Intel (INTC)-related opportunities that failed to materialize.&nbsp;Synopsys' stock has lost over 17% in 2025 and over 13% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/coreweave-surged-16-percent-today-and-retail-cannot-stop-talking-about-it/chwkQvmRduS">CoreWeave Surged 16% Today And Retail Can’t Stop Talking About The Stock – Find Out More</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Synopsys company logo is seen displayed on a smartphone screen. 

Why Did Synopsys Stock Tumble 34% Today?

The company’s Q3 revenue of $1.74 billion and adjusted earnings per share of $3.39 both came in below the analysts’ consensus estimate of $1.77 billion and $3.75, according to Fiscal AI data. 

Synopsys Q3 Earnings and Revenues Miss Estimates, Stock Plunges 22% 

SNPS stock plunges 22% after third-quarter earnings and revenues missed estimates, with weaker margins and lowered FY25 profit outlook weighing on shares.

Synopsys shares plunged 19.09% in extended trading on Tuesday after the company posted weaker-than-expected quarterly results and issued downbeat guidance.&nbsp;The slump, driven by setbacks in China following U.S. chip curbs, puts the stock on track for its worst day since August 2004 if losses carry into Wednesday’s session.Retail traders, however, reinforced their optimism, with their sentiment remaining at ‘extremely bullish’ (98/100) on Stocktwits. The message volume increased to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:615/55;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_09_at_11_00_41_PM_png_ae968a2451.webp" alt="Screenshot 2025-09-09 at 11.00.41 PM.png" width="615" height="55"><figcaption>SNPS sentiment and message volume as of 11 p.m. ET, Sept. 9 | source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/SNPS">Synopsys</a>,&nbsp;a provider of electronic design automation software products used to design and test integrated circuits, reported adjusted earnings per share (EPS) of $3.39 for the third quarter of the fiscal year 2025, missing the Fiscal.ai-compiled consensus of $3.75 and the guidance of $3.82-$3.87.&nbsp;Revenue climbed 14% year-over-year (YoY) to $1.74 billion, slightly below Wall Street’s average estimate of $1.77 billion.&nbsp;President and CEO of Synopsys, Sassine Ghazi, said, “While I'm proud of how our team navigated external challenges in the quarter, our IP business underperformed expectations. We are taking action to enhance our competitive advantage and drive resilient, long-term growth.”The executive noted a challenging geopolitical backdrop that dented the quarterly results.Clarifying further on the earnings call, Ghazi said the IP business suffered due to non-materialization of deals, according to a transcript made available by Koyfin. He flagged a three-way issue: new export restrictions disrupting design starts in China, challenges faced by a major foundry customer, and certain roadmap and resource decisions not yielding the desired results.For the fourth quarter, Synopsys expects adjusted EPS and revenue of $2.76-$2.80 and $2.23 billion-$2.26 billion. This trailed the consensus estimates of $4.14 and $2.59 billion, respectively.The company, however, raised the full-year revenue guidance to a range of $7.03 billion to $7.060&nbsp;billion from a range of $6.745 billion to $6.805 billion, which, however, was below the consensus estimate of $7.45 billion.It sharply reduced its adjusted EPS guidance, which also missed the average analysts’ estimate by a wide margin. =Synopsys stock has gained about 25% year-to-date (YTD).For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-oracle-stock-surged-in-after-hours-trading-today/chwjwOJRdMG">Why Oracle Stock Skyrocketed Nearly 30% In After-hours Trading Today</a>

In this photo illustration, a smartphone held in a hand shows the logo of Synopsys Inc, on September 4, 2025, in Chongqing, China. 

Why Synopsys Stock Plummeted 19% In After-Hours Trading Today

Synopsys CEO Sassine Ghazi talked about external challenges in the quarter that dented the company’s intellectual property business.

Compared to Estimates, Synopsys (SNPS) Q3 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Synopsys (SNPS) give a sense of how the business performed in the quarter ended July 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Synopsys (SNPS) Lags Q3 Earnings and Revenue Estimates

Synopsys (SNPS) delivered earnings and revenue surprises of -11.72% and -1.61%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

Small Biz Positive, New Jobs Revisions & Oracle Earnings On Deck

As we look forward to the unveiling of the iPhone 17, we also keep an eye out for year-long jobs revisions from the BLS.

Synopsys, Inc. engages in the provision of electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs). It also offers semiconductor intellectual property (IP) products. It operates through the following segments: Design Automation, Design IP, and Software Integrity. The Design Automation segment includes silicon design, verification products and services, system integration products and services, digital, custom, and FPGA IC design software, verification software and hardware products, and manufacturing software products. The Software Integrity segment includes a solution for building security and compliance testing into the customers' software development lifecycle and supply chain. The company was founded by Aart J. de Geus, Bill Krieger, Dave Gregory, and Rick Rudell in December 1986 and is headquartered in Sunnyvale, CA.

Synopsys, Inc.

Will Costco Wholesale ($COST) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

Stocktwits

Costco Wholesale Corp

) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

SNPS
Synopsys, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SNPS News

SNPS Synopsys, Inc.